CY1122166T1 - Διαταξη η οποια περιλαμβανει συστατικα αιματος για διαχωρισμο μοριων η σωματιδιων στοχων απο δειγματα - Google Patents

Διαταξη η οποια περιλαμβανει συστατικα αιματος για διαχωρισμο μοριων η σωματιδιων στοχων απο δειγματα

Info

Publication number
CY1122166T1
CY1122166T1 CY20191101074T CY191101074T CY1122166T1 CY 1122166 T1 CY1122166 T1 CY 1122166T1 CY 20191101074 T CY20191101074 T CY 20191101074T CY 191101074 T CY191101074 T CY 191101074T CY 1122166 T1 CY1122166 T1 CY 1122166T1
Authority
CY
Cyprus
Prior art keywords
particles
target molecules
sample
samples
separation
Prior art date
Application number
CY20191101074T
Other languages
English (en)
Inventor
Amar Rida
Nicolas Mermod
Patrice Francois
Vladimir Lazarevic
Jacques Schrenzel
Original Assignee
Debiopharm International Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm International Sa filed Critical Debiopharm International Sa
Publication of CY1122166T1 publication Critical patent/CY1122166T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Μια διάταξη συλλογής δειγμάτων για διαχωρισμό μορίων ή σωματιδίων στόχων από ένα δείγμα που περιλαμβάνει: (i) έναν κωδικό αναγνώρισης• (ii) ένα δοχείο για να δεχτεί το εν λόγω δείγμα• και (iii) ένα δείγμα το οποίο περιέχει ινωδογόνο στο δοχείο, με την διάταξη να μπορεί να λειτουργήσει για να σχηματίσει έναν θρόμβο ινώδους ο οποίος παγιδεύει κατά έναν διαχωρίσιμο τρόπο τα εν λόγω μόρια ή σωματίδια στόχους μετά από έκθεση του εν λόγω δείγματος σε θρομβίνη ή ένα ένζυμο τύπου θρομβίνης εντός της εν λόγω διάταξης, όπου η συγκέντρωση του ινωδογόνου εντός του εν λόγω δείγματος είναι μεταξύ 10 και 100 mg/ml.
CY20191101074T 2010-09-15 2019-10-11 Διαταξη η οποια περιλαμβανει συστατικα αιματος για διαχωρισμο μοριων η σωματιδιων στοχων απο δειγματα CY1122166T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH14782010 2010-09-15
CH20412010 2010-12-07
CH12072011 2011-07-20
EP11788227.4A EP2616550B1 (en) 2010-09-15 2011-09-15 Method for separating target molecules or particles from fibrinogen-containing samples including blood components
PCT/IB2011/054035 WO2012035508A2 (en) 2010-09-15 2011-09-15 Method for separating target molecules or particles from fibrinogen-containing samples including blood components

Publications (1)

Publication Number Publication Date
CY1122166T1 true CY1122166T1 (el) 2020-11-25

Family

ID=45044632

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191101074T CY1122166T1 (el) 2010-09-15 2019-10-11 Διαταξη η οποια περιλαμβανει συστατικα αιματος για διαχωρισμο μοριων η σωματιδιων στοχων απο δειγματα

Country Status (18)

Country Link
US (3) US9689881B2 (el)
EP (2) EP3067431B1 (el)
JP (1) JP5999776B2 (el)
KR (1) KR101948944B1 (el)
CN (2) CN107389932B (el)
AU (2) AU2011303467C1 (el)
CA (1) CA2811493C (el)
CY (1) CY1122166T1 (el)
DK (2) DK3067431T3 (el)
ES (2) ES2571127T3 (el)
HK (1) HK1247280A1 (el)
HR (1) HRP20191785T1 (el)
HU (2) HUE045771T2 (el)
LT (1) LT3067431T (el)
PL (2) PL3067431T3 (el)
PT (1) PT3067431T (el)
SI (1) SI3067431T1 (el)
WO (1) WO2012035508A2 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107389932B (zh) 2010-09-15 2019-11-22 德比奥法姆国际股份有限公司 用于从含纤维蛋白原的样品中分离目标分子或颗粒的方法
US9688959B2 (en) 2011-06-27 2017-06-27 Emory University Compositions, uses, and preparation of platelet lysates
US10444240B2 (en) * 2013-03-29 2019-10-15 Siemens Healthcare Diagnostics, Inc. Rare cell concentration
KR102571662B1 (ko) 2014-06-01 2023-08-25 데비오팜 인터네셔날 에스 에이 샘플 수집 및 가공 장치
US10960026B2 (en) 2016-03-10 2021-03-30 Arthrex, Inc. Systems and methods for preparing protein enhanced serums
CA3015664C (en) 2016-03-10 2023-10-31 Arthrex, Inc. Systems and methods for preparing a thrombin serum

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1035260A (en) * 1974-08-12 1978-07-25 Baxter Travenol Laboratories Collection and processing tube
FR2625321B1 (fr) * 1987-12-24 1992-10-02 Pasteur Institut Reactif pour le diagnostic de staphylococcus aureus par agglutination
ES2052781T3 (es) * 1988-01-05 1994-07-16 Linhart Axel Procedimiento y test-kit para la determinacion semicuantitativa del contenido de calcio en la sangre.
DE3803463A1 (de) * 1988-02-05 1989-08-17 Linhart Axel Semiquantitativer kalzium-schnelltest
US5691160A (en) * 1992-08-14 1997-11-25 Biogen, Inc. Effects of actin filaments of fibrin clot structure and lysis
EP0587398B1 (en) * 1992-09-09 1998-01-14 Tokuyama Corporation Method of assaying fibrinogen, dry reagent therefor, and process for the preparation thereof
JP3292760B2 (ja) * 1993-04-22 2002-06-17 テルモ株式会社 採血管およびその製造方法
US5670329A (en) * 1993-05-28 1997-09-23 Cardiovascular Diagnostics, Inc. Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field
CA2176810A1 (en) 1993-12-03 1995-06-08 Gordon L. Dorn Method for improving quantitative recovery of microorganisms from speci mens containing blood components
DE19602673A1 (de) * 1996-01-25 1997-08-07 Pereg Gmbh Synthetische Testanschmutzung
US6121232A (en) * 1997-01-31 2000-09-19 Omrix Biopharmaceuticals Sa Stabilized mixture comprising fibrinogen
US6680195B1 (en) * 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
JP2000262499A (ja) * 2000-01-01 2000-09-26 Terumo Corp 採血管
US6686204B2 (en) * 2001-08-27 2004-02-03 Becton, Dickinson & Company Collection device
CA2462599A1 (en) * 2001-10-03 2003-04-10 Christopher J. Woolverton Storage-stable fibrinogen solutions
DE60315151T2 (de) * 2002-05-01 2008-04-10 Synapse B.V. Diagnostischer test zur bestimmung der konzentration einer transienten proteolytischen aktivität in zusammengesetzten biologischen medien
DK1400589T3 (da) 2002-09-18 2006-11-27 Sirs Lab Gmbh Fremgangsmåde til påvisning af prokaryotisk DNA
ATE510931T1 (de) * 2003-08-15 2011-06-15 Univ South Florida Materialien und verfahren zur erfassung von pathogenen und entfernung von aurin- tricarbonsäure aus einer probe
US20050065454A1 (en) * 2003-09-22 2005-03-24 Becton, Dickinson And Company Non-evacuated blood collection tube
US7399609B2 (en) * 2003-12-30 2008-07-15 3M Innovative Properties Company Staphylococcus detection
US8419722B2 (en) * 2004-10-29 2013-04-16 Spinal Restoration, Inc. Apparatus and method for injection of fibrin sealant in spinal applications
DE102005009479A1 (de) 2005-03-02 2006-09-07 Molzym Gmbh & Co. Kg Verwendung von Nukleasen zum Abbau von Nukleinsäure in Gegenwart von chaotropen Agenzien und/oder Tensiden
EP1913144A1 (en) * 2005-07-29 2008-04-23 Ecole Polytechnique Fédérale de Lausanne Molecular variant fibrinogen fusion proteins
KR20150051243A (ko) * 2007-05-03 2015-05-11 아큐메트릭스, 인크. 트롬빈 수용체 길항제에 의한 혈소판 응집 억제의 측정 방법
AU2008281286B2 (en) 2007-08-02 2014-12-04 Universite Laval Concentration and enrichment of microbial cells and microbial nucleic acids from bodily fluids
JP5029217B2 (ja) * 2007-08-27 2012-09-19 東レ株式会社 シート状物の製造方法
CN102089322B (zh) * 2008-07-09 2015-09-23 普罗菲布瑞克斯公司 重组纤维蛋白原
CA2768485C (en) 2009-07-16 2018-12-04 Timothy Foster Treatment of staphylococci infections using recombinant fibrinogen binding protein clumping factor a
CN107389932B (zh) 2010-09-15 2019-11-22 德比奥法姆国际股份有限公司 用于从含纤维蛋白原的样品中分离目标分子或颗粒的方法

Also Published As

Publication number Publication date
AU2016266066A1 (en) 2016-12-22
ES2571127T3 (es) 2016-05-24
CN103108959B (zh) 2017-06-09
KR101948944B1 (ko) 2019-02-15
US20210148940A1 (en) 2021-05-20
PT3067431T (pt) 2019-10-29
JP5999776B2 (ja) 2016-09-28
WO2012035508A2 (en) 2012-03-22
CN103108959A (zh) 2013-05-15
EP3067431B1 (en) 2019-07-24
CN107389932B (zh) 2019-11-22
HK1247280A1 (zh) 2018-09-21
HUE045771T2 (hu) 2020-01-28
US9689881B2 (en) 2017-06-27
CA2811493C (en) 2020-06-16
HRP20191785T1 (hr) 2019-12-27
DK2616550T3 (en) 2016-05-23
WO2012035508A3 (en) 2012-05-18
AU2011303467A1 (en) 2013-04-04
AU2011303467B2 (en) 2016-09-15
US20130164737A1 (en) 2013-06-27
PL2616550T3 (pl) 2016-08-31
KR20130107300A (ko) 2013-10-01
DK3067431T3 (da) 2019-10-14
WO2012035508A4 (en) 2012-07-19
ES2751660T3 (es) 2020-04-01
LT3067431T (lt) 2019-11-11
US20170336424A1 (en) 2017-11-23
CA2811493A1 (en) 2012-03-22
CN107389932A (zh) 2017-11-24
PL3067431T3 (pl) 2019-12-31
AU2011303467C1 (en) 2017-03-09
HUE028915T2 (en) 2017-01-30
AU2016266066B2 (en) 2017-12-21
EP2616550B1 (en) 2016-02-10
SI3067431T1 (sl) 2019-11-29
EP2616550A2 (en) 2013-07-24
JP2013538355A (ja) 2013-10-10
EP3067431A1 (en) 2016-09-14

Similar Documents

Publication Publication Date Title
CY1122166T1 (el) Διαταξη η οποια περιλαμβανει συστατικα αιματος για διαχωρισμο μοριων η σωματιδιων στοχων απο δειγματα
CY1119972T1 (el) Προσδιορισμος για αντισωματα ιου jc
CY1121291T1 (el) Ανοσοδοκιμασιες ενισχυσης σηματος
Bang-Christensen et al. Capture and detection of circulating glioma cells using the recombinant VAR2CSA malaria protein
CY1123496T1 (el) Μεθοδοι για την ανιχνευση συμμετρικης διμεθυλαργινινης
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
EA200971124A1 (ru) Множественный анализ образцов крови
HRP20231232T1 (hr) Otkrivanje pogrešno savijenih proteina
BR112018000851A2 (pt) sistemas e métodos para detecção e quantificação aprimoradas de analitos
BR112014010718A2 (pt) métodos e sistemas para detecção de analito em amostra
CY1118544T1 (el) Προσδιορισμος ολικου αιματος
DK1730518T3 (da) Fremgangsmåde, chip, anordning og integreret system til detektering af biologiske partikler
EA201171046A1 (ru) Зонды и праймеры для детектирования вируса чикунгуньи
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
BRPI0618713B8 (pt) cardiolipina modificada e seus usos
DK1730519T3 (da) Fremgangsmåde, chip og system til opsamling af biologiske partikler
BRPI0518405A2 (pt) detecÇço de vÍrus papiloma humano (hpv) utilizando sondas de Ácido nuclÉico, microcontas e separador de cÉlulas ativado fluorescente (facs)
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
WO2018213790A8 (en) Apparatus for analyzing and detecting interactions and reactions of molecules
EA201300008A1 (ru) Недорогие электродные чипы (варианты) и способы многокомпонентного анализа и оценки на основе катодной электролюминесценции
EA201991506A1 (ru) Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов
EA201500377A1 (ru) Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул
JPWO2016117701A1 (ja) ターゲット分析用具およびターゲット分析方法
GB2522131A (en) Isotopic labelling of proteins
EA201650035A1 (ru) Пробирный анализ для определения антикоагулянтов в крови или в плазме крови